Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Precision Trials Az LLC

Neither a doctor nor a teaching hospital

Research payments

$4,161,341

348 payments

Through program year 2025, Precision Trials Az LLC is reported as receiving $4,161,341 in research payments, across 348 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $652,872 60
2024 Research $848,604 70
2023 Research $772,264 56
2022 Research $684,065 56
2021 Research $868,529 46
2020 Research $115,557 35
2019 Research $219,450 25

Breakdown

Who paid Research payments · program years 2019–2025
  1. Evofem Biosciences, Inc. $1,286,900 53 payments
  2. Astellas Pharma Global Development $1,110,150 100 payments
  3. Mylan Inc. $736,856 28 payments
  4. Organon LLC $615,776 77 payments
  5. Mitsubishi Tanabe Pharma Development America, Inc. $171,737 4 payments
  6. Bayer HealthCare Pharmaceuticals Inc. $163,738 63 payments
  7. GlaxoSmithKline, LLC. $28,001 5 payments
  8. Genentech, Inc. $19,121 5 payments
  9. SCYNEXIS, Inc. $18,175 3 payments
  10. Pfizer Inc. $7,228 5 payments
Studies the money was for Research payments · program years 2019–2025
  1. A Phase IV, Longitudinal, Observational Study Examining Real-World Outcomes of Non-Hormonal Pharmacotherapies Among Individuals Treated for Bothersome Vasomotor Symptoms $1,110,150 100 payments
  2. Mr-100A-01-Td-3001-A Phase 3, Multicenter, Open-Label, Single Arm Study of Mr-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety $736,856 28 payments
  3. Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection $685,034 23 payments
  4. Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) $563,227 26 payments
  5. Efficacy and Safety of Nexplanon 36 to 60 Months Post Insertion $131,592 13 payments
  6. Og-8175A-023 $115,247 11 payments
  7. BAY1454032 Essure System for Permanent Birth Control $103,521 12 payments
  8. An Open-label, Long Term Extension Study of MT-8554 in Postmenopausal Women Experiencing Moderate to Severe Vasomotor Symptoms Who Completed Study MT-8554-A01 $98,677 2 payments
  9. 8415-8415-060-PN060-Extended Duration Study (Celanese + 2 years)-Contraception-SC-imp-Supplemental Registration-USA-LD-B $84,194 1 payment
  10. A Phase 3, Open-label, Multi-center, Single Arm Study to Assess Contraceptive Efficacy and Safety of the Etonogestrel MK-8415 Implant During Extended Use From 3 Years After Insertion in Females 35 Years of Age or Younger $69,089 7 payments
What the money was spent on Research payments · program years 2019–2025
  1. Professional salary support $1,087,459 47 payments
  2. Patient care $633,551 79 payments
  3. Overhead $400 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record